Cherry Creek Investment Advisors, Inc.

Position in IBRX — ImmunityBio, Inc.

CIK 1877829 ENGLEWOOD, CO

Position in IBRX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$653,832

+$81,796 QoQ

Shares Held

74,681

+0.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#140

of 401 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cherry Creek Investment Advisors, Inc. holds $1,639,883 across 4 Biotechnology names. IBRX ranks #1 (39.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc. This page	74,681	$653,832
2	VRTX	Vertex Pharmaceuticals Inc / Ma	770	$382,482
3	ABSI	Absci Corp	31,495	$365,027
4	RXRX	Recursion Pharmaceuticals, Inc.	64,998	$238,542

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$653,832	74,681	+0.1%	Shares	Sole	2026-07-30
2026-03-31	$572,036	74,581	+435.5%	Shares	Sole	2026-04-30
2025-12-31	$27,577	13,928	—	Shares	Sole	2026-01-15
No filing history on record for this holder in this stock.